pak 104p has been researched along with leukotriene c4 in 2 studies
Studies (pak 104p) | Trials (pak 104p) | Recent Studies (post-2010) (pak 104p) | Studies (leukotriene c4) | Trials (leukotriene c4) | Recent Studies (post-2010) (leukotriene c4) |
---|---|---|---|---|---|
16 | 0 | 0 | 1,260 | 40 | 193 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, SI; Chen, ZS; Chuman, Y; Furukawa, T; Haraguchi, M; Seto, K; Shudo, N; Sumizawa, T; Tani, A | 1 |
Akiyama, SI; Aoki, S; Chen, ZS; Furukawa, T; Kawabe, T; Kuwano, M; Ono, M; Sumizawa, T; Uchiumi, T; Wada, M | 1 |
2 other study(ies) available for pak 104p and leukotriene c4
Article | Year |
---|---|
Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.
Topics: Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzylisoquinolines; Cyclic P-Oxides; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Humans; Leukotriene C4; Multidrug Resistance-Associated Proteins; Nicotinic Acids; RNA, Messenger; Tumor Cells, Cultured; Verapamil; Vincristine | 1997 |
Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter.
Topics: Adenosine Triphosphate; Animals; Anion Transport Proteins; Antineoplastic Agents; Biological Transport; Carrier Proteins; Cells, Cultured; Cyclic P-Oxides; Cyclosporine; Drug Interactions; Drug Resistance, Multiple; Glutathione; Humans; Kinetics; Leukotriene C4; Nicotinic Acids; Osmolar Concentration; Propionates; Quinolines; Swine; Transfection; Tritium; Vincristine | 1999 |